Patent · US Active

Anti-LRP5 antibodies and methods of use

US9522954B2 · kind B2 · utility

1Cited by
0References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2015
Grant dateDec 20, 2016
Priority date—
Expiry dateOct 9, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-LRP5 antibodies and methods of making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.